tirzepatide fda approved Approves (Zepbound) as the First Medication for Obstructive Sleep Apnea FDA Grants Tirzepatide a New

Top of mind for the fillfinish market on the CDMO/CMO side is Novo Holdings $16.5-billion acquisition of the CDMO, Catalent, a deal which closed last December (December 2024) and Novo Holdings subsequent sale of three fillfinish sites to Novo Nordisk for $11 billion to support Novo Nordisks blockbuster GLP-1 agonists, Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity

Each prescription is individualized, and BUD timing, dose, and concentration may differ

We'll help you understand whether a Semaglutide or Tirzepatide program is right for your goals

Understanding your personal risk profile for both efficacy and side effects allows treatment adjustments before they become problematic, emphasizing the value of personalized dosing strategies and monitoring

10.1177/09636897211010633 46 LiuR.LiA.LangY.CaiH.TangX.LiD.et al (2023)

Earlier this year, California introduced legislation to restrict the influence of private equity in healthcare (AB 1415) and bolster the states CPOM enforcement capabilities (SB 351)